What's new

Human medicines European public assessment report (EPAR): Camzyos, mavacamten, Date of authorisation: 26/06/2023, Revision: 5, Status: Authorised

Human medicines European public assessment report (EPAR): Camzyos, mavacamten, Date of authorisation: 26/06/2023, Revision: 5, Status: Authorised

Jun 2, 2025 - 16:20
 0
Human medicines European public assessment report (EPAR): Camzyos, mavacamten, Date of authorisation: 26/06/2023, Revision: 5, Status: Authorised
Human medicines European public assessment report (EPAR): Camzyos, mavacamten, Date of authorisation: 26/06/2023, Revision: 5, Status: Authorised
Read More

Tags:

Previous Article

Meeting summary - Medicine shortages (SPOC) working party 10-11 April 2025

Next Article

Human medicines European public assessment report (EPAR): Opdivo, nivolumab, Dat...

Related Posts

EMA/FVE info session for veterinary practitioners : Understanding the first report of sales and use of antimicrobials in animals, Online, European Medicines Agency, Amsterdam, the Netherlands, from 3 June 2025, 15:30 (CEST) to 3 June 2025, 16:30 (CEST)

EMA/FVE info session for veterinary practitioners : Und...

Jun 5, 2025  0

Human medicines European public assessment report (EPAR): Ovaleap, follitropin alfa, Date of authorisation: 27/09/2013, Revision: 13, Status: Authorised

Human medicines European public assessment report (EPAR...

May 27, 2025  0

Fiasp PumpCart (insulin aspart)

Fiasp PumpCart (insulin aspart)

May 12, 2025  0